Showing 1 - 10 of 8108 results

Caring for the Ages

April 6, 2026

Getting Functional Medicine on the PALTC Radar

Even as people age, lifestyle and other changes can still positively impact outcomes, well-being, and longevity. So, it’s not surprising that functional medicine, which involves a holistic, person-centered approach to health care that focuses on root causes of illness instead of just treating symptoms, is ...
Caring for the Ages

April 6, 2026

Celebrating 30 Years of Impact—Advancing PALTC Together

As the Foundation for Post-Acute and Long-Term Care Medicine begins its 30th year, we are reflecting on the remarkable impact made possible by the generosity and commitment of our national community.
Caring for the Ages

April 6, 2026

April JAMDA Highlight

One of our highlighted articles for the current issue of JAMDA is the brief report by Dr. Deardorff and team, Can I Stay, or Must I Go Now? A Cohort Study of Discharge Appeals in a Post-Acute Skilled Nursing Facility.
Policy Snapshot

April 6, 2026

CMS Invites ACOs to Apply to the New LEAD Model

CMS released the Request for Applications (RFA) for the Long-term Enhanced ACO Design (LEAD) Model, which aims to expand the benefits of Accountable Care Organizations (ACOs) to more Medicare beneficiaries. The model supports a broad range of participants and providers by offering enhanced support to small...
Policy Snapshot

April 6, 2026

CMS Updates State Operations Manual for Nursing Homes

The Centers for Medicare & Medicaid Services (CMS) has finalized revisions to the State Operations Manual (SOM) governing nursing home surveys and complaint investigations. The guidance was initially released through QSO 26 03 NH on January 30, 2026, with revisions to Chapters 5 and 7, and was subseque...
Policy Snapshot

April 6, 2026

CMS Releases Proposed FY 2027 SNF PPS Rule

The Centers for Medicare & Medicaid Services (CMS) has released the Fiscal Year (FY) 2027 Skilled Nursing Facility Prospective Payment System (SNF PPS) Proposed Rule, outlining several proposed updates to Medicare payment rates, quality programs, and data reporting requirements for skilled nursing faci...
Caring for the Ages

April 6, 2026

Suzetrigine: A First-in-Class Non-Opioid Analgesic — Promise With Vigilance

Suzetrigine (brand name Journavx) is a recently approved, first-in-class, oral, non-opioid analgesic indicated for the treatment of moderate to severe acute pain in adults. Approved by the U.S. Food and Drug Administration (FDA) in 2025, it represents the first novel mechanistic class of oral analgesic in ...

Advertisement

 

Advertisement